- Home
- CRMD vs NRK Comparison
CRMD vs NRK Comparison
Compare CRMD & NRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRMD | NRK |
|---|---|---|
| Founded | 2006 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 958.1M | 878.5M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRMD | NRK |
|---|---|---|
| Price | $6.82 | $10.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $17.29 | N/A |
| AVG Volume (30 Days) | ★ 4.0M | 187.3K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.10% |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.25 | N/A |
| Revenue | ★ $214,303,672.00 | N/A |
| Revenue This Year | $628.67 | N/A |
| Revenue Next Year | $14.64 | N/A |
| P/E Ratio | $3.11 | ★ N/A |
| Revenue Growth | ★ 1647.67 | N/A |
| 52 Week Low | $5.60 | $8.95 |
| 52 Week High | $17.43 | $11.09 |
Technical Indicators
Market Signals| Indicator | CRMD | NRK |
|---|---|---|
| Relative Strength Index (RSI) | 22.73 | 58.78 |
| Support Level | $7.01 | $10.09 |
| Resistance Level | $7.44 | $10.28 |
| Average True Range (ATR) | 0.66 | 0.05 |
| MACD | -0.53 | 0.02 |
| Stochastic Oscillator | 0.40 | 75.00 |
Price Performance
Historical ComparisonAbout CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About NRK Nuveen New York AMT-Free Quality Municipal Income Fund
Nuveen New York AMT-Free Quality Municipal Income Fund is a closed-end investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.